Walleye Capital’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$66.4K Sell
12,300
-11,000
-47% -$65.8K ﹤0.01% 3814
2025
Q4
$162K Buy
+23,300
New +$153K ﹤0.01% 3646
2025
Q2
Sell
-100
Closed -$647 4521
2025
Q1
$647 Sell
100
-2,100
-95% -$15.1K ﹤0.01% 4152
2024
Q4
$17.7K Sell
2,200
-58,700
-96% -$484K ﹤0.01% 4520
2024
Q3
$497K Sell
60,900
-32,500
-35% -$214K ﹤0.01% 3305
2024
Q2
$651K Buy
93,400
+91,200
+4,145% +$690K ﹤0.01% 3269
2024
Q1
$23.3K Buy
+2,200
New +$19.2K ﹤0.01% 4887
2023
Q3
Sell
-106,300
Closed -$850K 4881
2023
Q2
$850K Buy
+106,300
New +$784K ﹤0.01% 1986
2023
Q1
Sell
-300
Closed -$1.88K 3939
2022
Q4
$1.88K Buy
+300
New +$2.1K ﹤0.01% 2997
2020
Q2
Sell
-12,000
Closed -$186K 620
2020
Q1
$186K Sell
12,000
-123,500
-91% -$2.98M 0.04% 456
2019
Q4
$4.05M Buy
135,500
+23,900
+21% +$621K 0.26% 69
2019
Q3
$2.44M Buy
111,600
+65,600
+143% +$1.5M 0.15% 175
2019
Q2
$1.16M Buy
46,000
+11,500
+33% +$273K 0.13% 217
2019
Q1
$852K Buy
+34,500
New +$824K 0.14% 216

Other funds holding BHC

Walleye Capital's BHC Position: Q1 2026 in Review

Walleye Capital increased its Bausch Health (BHC) stake by 8,380% in Q1 2026, buying an estimated $6.96M and bringing the position to 1,177,370 shares worth $6.36M. The position accounts for 0.03% of the portfolio, ranked #647.

Walleye Capital first reported a position in BHC in Q1 2019 and has held it in 11 quarters since. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

  • Walleye Capital held 1,177,370 shares of Bausch Health worth $6.36M as of Q1 2026.
  • Walleye Capital bought 1,163,486 Bausch Health shares in Q1 2026, an estimated $6.96M.
  • Bausch Health made up 0.03% of Walleye Capital's portfolio in Q1 2026, its #647 holding.
  • Walleye Capital first reported a position in Bausch Health in Q1 2019 and has held it in 11 quarters since.
  • 227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.